THE LABORATORY AND CLINICAL ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE (M & B 7714) AGAINST POX VIRUSES
- 1 July 1965
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 130 (1) , 118-127
- https://doi.org/10.1111/j.1749-6632.1965.tb12546.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A New Antiviral Agent : 4-Bromo-3-methylisothiazole-5-carboxaldehyde thiosemicarbazone, M and B 7714Nature, 1964
- 376. Isothiazoles. Part II. Isothiazolealdehydes and isothiazolyl ketonesJournal of the Chemical Society, 1963
- THE STRUCTURE‐ACTIVITY RELATIONSHIPS OF THE ANTIVIRAL CHEMOTHERAPEUTIC ACTIVITY OF ISATIN β‐THIOSEMICARBAZONEBritish Journal of Pharmacology and Chemotherapy, 1960
- 613. Isothiazole: a new mononuclear heterocyclic systemJournal of the Chemical Society, 1959
- Vaccination against mouse-pox: With a note on the suitability of vaccinated mice for work on chemical induction of skin tumoursThe Journal of Pathology and Bacteriology, 1957
- THE ANTIVIRAL AND SYNERGIC ACTIONS OF ISATIN THIOSEMICARBAZONE AND CERTAIN PHENOXYPYRIMIDINES IN VACCINIA INFECTION IN MICE1955
- Effect of Heterocyclic and Other Thiosemicarbazones on Vaccinia Infection in the MouseThe Journal of Immunology, 1953